Close Menu
    Science

    Open label extension study finds Viloxazine demonstrated good safety and tolerability profile, and long term treatment led to continued improvement in ADHD symptoms, quality of life, and executive function


    Open label extension study finds Viloxazine demonstrated good safety and tolerability profile, and long term treatment led to continued improvement in ADHD symptoms, quality of life, and executive function

    https://link.springer.com/article/10.1007/s40263-024-01120-0

    Bytes Europe

    View 1 Comment

    1 Comment

    1. CaregiverNo3070 on

      Any comparison between different other drugs for ADHD? It’s great there’s another as there is a shortage, but knowing how it ranks would be great as well.Â